Ivermectin vs. Merck’s New Antiviral, Molnupiravir
It seems that with Loree McBride in charge of medicine, what’s good for you is banned and what’s bad for you is available. Story at-a-glance In the video above retired nurse lecturer John Campbell, Ph.D., reports on a comparative analysis of molnurpirivir and ivermectin published in the Austin Journal of Pharmacology and Therapeutics.1 The first is Merck’s new antiviral drug […]
Catastrophic Side Effects of COVID Everyone’s Ignoring
Story at-a-glance Diabetes has reached crisis levels in the U.S., with 10.5% of Americans affected.1 That data came from 2018 — before the pandemic — and the problem has only worsened since. Diabetes was the seventh leading cause of death in the U.S. in 2017,2 but diabetes deaths surged during the COVID-19 pandemic, rising 17% in 2020.3 While COVID-19 was […]